Egypt Records 1651 New Cases of COVID-19    United States condemns Houthi attacks on Saudi Arabia and UAE    Police arrest 2 Saudis who ran over and robbed passerby in Riyadh    Al-Rumayyan: iktva program attracts over 500 investments in Saudi Arabia    Al-Qasabi calls for Saudi-Iraqi business forum to be held annually    Ehsan platform launches application for smartphones    King Salman receives written message from president of South Sudan    Approval of 3 ministries required to obtain rural tourism license    Yara Ghouth launches 'Naseej Market' to craft the way for craftsmen Built by locals, for locals    EP Emir inaugurates Gulf region's largest fish island in Qatif    MoH: Children need to take second dose of vaccine Omicron is only variant found in Kingdom    Burkina Faso president reportedly detained by military    As millions fall behind, how can we bridge the growing education gap?    Navratilova blasts Peng Shuai T-shirt ban at Australia Open    Newcastle United land in Saudi Arabia for training camp    Cirque du Soleil to establish an academy and regional office in Saudi Arabia    Saudi Arabia, Romania Sign Defense Cooperation Agreement    34th International "Virtual" Conference for Muslims of Latin America, Caribbean kicked off today    Jordan Records 11,478 New Infections of COVID-19    OIC Condemns Terrorist Attack on Civilian Areas in the Kingdom and the UAE    In Implementation of the Custodian of the Two Holy Mosques Directives, Validity of Iqama, Exit, Re-entry and Visitor Visas Extended Automatically and Free of Charge    Governor of Eastern Region Inaugurates 6th iktva Forum and Exhibition    "Adaa" Observes Saudi Arabia's Progress in the Field of Education Globally    Saudi Arabia to Host LEAP, Global Technology Platform, to Address Challenges Facing Humanity    MAWANI Boosts Saudi Arabia's Bid to Become Global Logistics Hub    Kuwait Condemns Houthi Militia's Terrorist Attacks on Saudi Arabia and UAE    Order of King Abdulaziz awarded to former OIC chief    Omani National Football Team Arrives in Jeddah to Meet Saudi National Team    GEA launches 'Squid Game experience' as part of Riyadh Season    'Bab Al Hara' Director Bassam AlMulla passes away at 65    Saudi Handball Team Loses to Qatar in Main Round of 2022 Asian Men's Handball Championship    Eighth Season of ABB FIA Formula E World Championship to kick off in Diriyah    Bocelli performs in AlUla in third Winter at Tantora    700 women footballers vie for a place in first-ever national team Jeddah hosts Green Ladies' first training camp    20th Asian Handball Championship Main Round to Kick off Tomorrow    Tearful Adele postpones entire Las Vegas residency    Riyadh's Qualitative Events Enrich its Winter, Attract World Attention    SFDA: Fat is a Source of Energy and Its Abundance is Linked to Chronic Diseases    Reflections on celebration of Christmas    Royal Commission for AlUla to Hold Custodian of the Two Holy Mosques Endurance Cup 2022, Richard Mille AlUla Desert Polo    Saudi Arabia's Pavilion at Expo 2020 Dubai Organizes a Dance Theatrical Show for Children    Saudi Arabia rebuffs UN resolution on 'sexual orientation'    Kabir Khan eyes on joint Indian – Saudi film projects    Bollywood superstar Salman Khan to dazzle Riyadh Season on Dec. 10    Pilgrims Perform Dhuhr and Asr Prayers at Arafat Holy Site    Council of Senior Scholars: Muslim Brothers' Group Don't Represent Method of Islam, rather only Follows its Partisan Objectives, Violating our Graceful Religion    Eid Al-Adha Prayer Performed at the Grand Holy Mosque    Pilgrims Perform Dhuhr and Asr Prayers in Arafat Holy Site    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



EU medicines regulator approves Pfizer/BioNTech COVID-19 vaccine
Published in The Saudi Gazette on 21 - 12 - 2020

The European Medicines Agency (EMA) has recommended the use of the Pfizer-BioNTech COVID-19 vaccine in the European Union.
The authorization will pave the way for a possible start of vaccinations in Europe on Dec. 27.
After EMA scientists concluded that the vaccine is safe, officials at the Amsterdam-based agency recommended its conditional approval for it to be distributed across the 27-nation bloc.
The European Commission must still rubber-stamp the decision before the vaccine can be rolled out.
Head of the European Commission Ursula von der Leyen said the European Commission will now act fast and decide on the authorization tonight.
The pharmaceutical companies will also need to submit follow-up data on their vaccine for the next year.
In the press conference announcing the recommendation, Dr. Harald Enzmann, Chairman of the Committee for Medicinal Products for Human Use (CHMP) said the vaccine study offered an unusually large amount of data on how elderly people react to the vaccine.
More than 1,600 people over 75 took part in the study, which is highly unusual. In that group, the vaccine showed a 95 percent efficacy rate.
EMA, he said, has set the lower limit for vaccination at 16-year-olds.
Moreover, Enzmann said, there is not enough data on how pregnant women react to the vaccine. Thus, "we recommend a case by case decision" dependent on their exposure and risk, he noted. The number of pregnant women in the clinical study is "in the single digits," he added.
Moreover, he said it is still unclear whether those vaccinated may still be able to transmit the virus. Until there is more information with regards to transmission, he recommends that those who have successfully completed their vaccination to "please wear masks and keep your distance."
Sabine Straus, Chair of EMA's Safety Committee noted that more than 80,000 people have received the vaccine during the clinical study. The side effects that have been displayed are similar to those of other vaccines, such as pain at the injection site, tiredness, headache, muscle, and joint pain, or fever. Those symptoms usually last for a day.
Straus also pointed out that there have been very small numbers of allergic reactions to the vaccine. Based on these observations, people will now be closely observed for at least 15 minutes after getting the shot.
She added that generally, vaccines are only authorized if the benefits outweigh the risks, stressing that pharmaceutical companies will also have to send monthly updates about new findings. Usually, they only have to send those updates every six months.
EMA has also commissioned independent scientific studies to monitor the safety of the vaccine in its real-life application.
With regards to the newest strain of COVID-19 currently spreading across the UK and South Africa, the agency stated that this vaccine is likely to offer protection against the new variant.
The European regulator came under heavy pressure last week from countries calling for the vaccine to be granted approval for use as quickly as possible.
EMA had originally set December 29 as the date for its evaluation of the vaccine, made by Germany-based BioNTech, but moved the meeting forward after pressure from Berlin and other member states.
The EU's approval of the vaccine comes roughly three weeks after Britain, which has started administering the jab to its citizens. — Euro news


Clic here to read the story from its source.